I enjoyed reading the comments on yesterday's post regarding the positive results of the ESSENCE trial of semaglutide vs placebo in patients with metabolic dysfunction-associated steatohepatitis (MASH). Thank you to those who took the time to write.
I wanted to share some very brief thoughts on two basic tenets of medical practice that emerged from the thoughtful commentary.
Keep reading with a 7-day free trial
Subscribe to Sensible Medicine to keep reading this post and get 7 days of free access to the full post archives.